Literature DB >> 8475122

Human immunoglobulin heavy-chain minilocus recombination in transgenic mice: gene-segment use in mu and gamma transcripts.

N Tuaillon1, L D Taylor, N Lonberg, P W Tucker, J D Capra.   

Abstract

We (N.L. and L.D.T.) have introduced a human heavy-chain minilocus into mice transgenically. Constructs contain 2 heavy-chain variable (VH; psi VH3-105 and VH5-251), 10 diversity (D), 6 heavy-chain joining (JH), and either constant (C)mu or C mu and C gamma gene segments. Several founder lines were established and studied before immunization. Seventy heavy-chain transcripts were cloned and sequenced from murine splenic B lymphocytes, and gene-segment use was assessed before and after class-switching. In general, the repertoire was "fetal" in appearance with little evidence of somatic mutation in any gene segment. The two VH gene segments were found rearranged to mu- and gamma-chain C segments, with a preference of VH5-251. We observed a preponderance of the most-J-proximal D gene (DHQ52) segments among the mu transcripts (44%). The JH gene-segment use mimics most patterns seen in human antibodies. Diversification in CDR3 was extensive and included clear examples of D inversions and D-D fusions. These data suggest that a human immunoglobulin minilocus can undergo recombinatorial processes in a manner analogous to that seen in the human fetal/preimmune repertoire. This model, in addition to providing a potential source of human monoclonal antibodies, is ideal for the study of further questions concerning immunoglobulin gene-segment recombination.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8475122      PMCID: PMC46373          DOI: 10.1073/pnas.90.8.3720

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Class switch recombination is IgG1 specific on active and inactive IgH loci of IgG1-secreting B-cell blasts.

Authors:  A Radbruch; W Müller; K Rajewsky
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

2.  Switch region content of hybridomas: the two spleen cell Igh loci tend to rearrange to the same isotype.

Authors:  M Hummel; J K Berry; W Dunnick
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Immunoglobulin class switching.

Authors:  A Shimizu; T Honjo
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

5.  Early restriction of the human antibody repertoire.

Authors:  H W Schroeder; J L Hillson; R M Perlmutter
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

6.  A transgenic mouse that expresses a diversity of human sequence heavy and light chain immunoglobulins.

Authors:  L D Taylor; C E Carmack; S R Schramm; R Mashayekh; K M Higgins; C C Kuo; C Woodhouse; R M Kay; N Lonberg
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

7.  Human heavy-chain variable region gene family nonrandomly rearranged in familial chronic lymphocytic leukemia.

Authors:  A Shen; C Humphries; P Tucker; F Blattner
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

8.  A new human immunoglobulin VH family preferentially rearranged in immature B-cell tumours.

Authors:  C G Humphries; A Shen; W A Kuziel; J D Capra; F R Blattner; P W Tucker
Journal:  Nature       Date:  1988-02-04       Impact factor: 49.962

9.  Deletion of immunoglobulin heavy chain genes from expressed allelic chromosome.

Authors:  Y Yaoita; T Honjo
Journal:  Nature       Date:  1980-08-28       Impact factor: 49.962

10.  Directed Ig class switch recombination in activated murine B cells.

Authors:  E Winter; U Krawinkel; A Radbruch
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

View more
  8 in total

1.  Use of D gene segments with irregular spacers in terminal deoxynucleotidyltransferase (TdT)+/+ and TdT-/- mice carrying a human Ig heavy chain transgenic minilocus.

Authors:  N Tuaillon; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

2.  Recombinant human IgA expressed in insect cells.

Authors:  L Carayannopoulos; E E Max; J D Capra
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

Review 3.  Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Authors:  Saul Tzipori; Abhineet Sheoran; Donna Akiyoshi; Arthur Donohue-Rolfe; Howard Trachtman
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

Review 4.  The molecular structure of human antibodies specific for the human immunodeficiency virus.

Authors:  J S Andris; J D Capra
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

5.  Antibodies generated from human immunoglobulin miniloci in transgenic mice.

Authors:  S D Wagner; G T Williams; T Larson; M S Neuberger; D Kitamura; K Rajewsky; J Xian; M Brüggemann
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

6.  Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice.

Authors:  Andrew J Murphy; Lynn E Macdonald; Sean Stevens; Margaret Karow; Anthony T Dore; Kevin Pobursky; Tammy T Huang; William T Poueymirou; Lakeisha Esau; Melissa Meola; Warren Mikulka; Pamela Krueger; Jeanette Fairhurst; David M Valenzuela; Nicholas Papadopoulos; George D Yancopoulos
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-25       Impact factor: 11.205

7.  Localization of the binding site for the monocyte immunoglobulin (Ig) A-Fc receptor (CD89) to the domain boundary between Calpha2 and Calpha3 in human IgA1.

Authors:  L Carayannopoulos; J M Hexham; J D Capra
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

Review 8.  The shape of the lymphocyte receptor repertoire: lessons from the B cell receptor.

Authors:  Katherine J L Jackson; Marie J Kidd; Yan Wang; Andrew M Collins
Journal:  Front Immunol       Date:  2013-09-02       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.